News
News releases on January 2, 2024, page 3
Every news release public companies put out on January 2, 2024 (UTC): 339 news releases, newest first. Open any release to read it.
Nextracker Appoints Two New Members to Board of Directors
Nextpower Inc. · Jan 2, 2024
Nextracker Appoints Two New Members to Board of Directors
Flex Ltd. · Jan 2, 2024
Nextracker Announces Completion of Its Separation from Flex
Nextpower Inc. · Jan 2, 2024
Neurocrine Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Neurocrine Biosciences, Inc. · Jan 2, 2024
NeuroBo to Participate in Industry and Investor Conferences in January
MetaVia Inc. · Jan 2, 2024
Neumora Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
Neumora Therapeutics, Inc. · Jan 2, 2024
NESR Announces Participation in Upcoming Conferences
National Energy Services Reunited Corp · Jan 2, 2024
NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
NeoGenomics, Inc. · Jan 2, 2024
Nature’s Sunshine Announces Participation at the 26th Annual Needham Growth Conference on January 19, 2024
Nature's Sunshine Products, Inc. · Jan 2, 2024
MediaCo Holding Inc. Announces Chris Squire as Senior Vice President of Sales and Marketing for HOT 97 and WBLS
Mediaco Holding Inc. · Jan 2, 2024
MEDIA ALERT: Rambus to Present at 26th Annual Needham Growth Conference
Rambus, Inc. · Jan 2, 2024
MannKind and Sagard Healthcare Enter Into Royalty Purchase Agreement for Up to $200 Million
MannKind Corporation · Jan 2, 2024
Loyalist Exploration Limited Announces Retirement of Chairman
Loyalist Exploration Limited · Jan 2, 2024
Liquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
Liquidia Corporation · Jan 2, 2024
Lands' End Announces Participation in the 26th Annual ICR Conference
Lands' End Inc · Jan 2, 2024
Lands’ End Announces New Term Loan
Lands' End Inc · Jan 2, 2024
Kymera Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024
Kymera Therapeutics, Inc. · Jan 2, 2024
Kodiak Robotics Selects Ambarella AI Domain Controller SoC For Next-Generation Autonomous Trucks
Ambarella, Inc. · Jan 2, 2024
Knightscope Authorized Partner TS&L Purchases First 13 K1 Blue E-Phones for Georgia State University
Knightscope, Inc. · Jan 2, 2024
Kiniksa Pharmaceuticals to Present at 42nd Annual J.P. Morgan Healthcare Conference
Kiniksa Pharmaceuticals International, plc · Jan 2, 2024
Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million
Journey Medical Corporation · Jan 2, 2024
J & J Snack Foods schedules conference call to discuss first quarter financial results
J & J Snack Foods Corp. · Jan 2, 2024
Jasper Therapeutics, Inc. Announces Reverse Stock Split
Jasper Therapeutics, Inc. · Jan 2, 2024
IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference
iRadimed Corporation · Jan 2, 2024
Interactive Brokers Group Reports Brokerage Metrics and Other Financial Information for December 2023, includes Reg.-NMS Execution Statis...
Interactive Brokers Group, Inc. · Jan 2, 2024
Interactive Brokers Appoints Rich Repetto to its Board of Directors
Interactive Brokers Group, Inc. · Jan 2, 2024
Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
QTREX Quantum Ltd. · Jan 2, 2024
Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
Insmed Incorporated · Jan 2, 2024
INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune™ in Patients with Metastatic Castration-Resistant Prostate Cancer
INmune Bio Inc. · Jan 2, 2024
Immunome Appoints Carol A. Schafer to Board of Directors
Immunome, Inc. · Jan 2, 2024
ImmunityBio Announces $320 Million Investment by Oberland Capital, with $210 Million Funded at Closing, Bringing Total Financing in 2023 ...
ImmunityBio, Inc. · Jan 2, 2024
IMC Announces the Conclusion of the Planning and Construction Legal Proceedings
IM Cannabis Corp. · Jan 2, 2024
Ichor Announces Participation in 26th Annual Needham Growth Conference
Ichor Holdings · Jan 2, 2024
Hydrofarm Holdings Group to Participate in the 2024 ICR Conference
Hydrofarm Holdings Group, Inc. · Jan 2, 2024
HF Foods To Participate in the 2024 ICR Conference
HF Foods Group Inc. · Jan 2, 2024
Heritage Mining Announces $500,000 Non-Brokered Private Placement of Units and OJEP Approval (Repeat Relase from December 29)
Heritage Mining Ltd. · Jan 2, 2024
Healthcare Triangle, Inc. Completes $2.0 Million Private Placement Debt Offering
Healthcare Triangle, Inc. · Jan 2, 2024
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer
Guardant Health, Inc. · Jan 2, 2024
Good Times Restaurants Inc. Welcomes Keri August as Senior Vice President of Finance and Accounting
Good Times Restaurants Inc. · Jan 2, 2024
GlucoTrack announces early accuracy data for its implantable continuous glucose monitor
GlucoTrack, Inc. · Jan 2, 2024
GameSquare Completes the Sale of Its Non-Core Radio Business Assets
GameSquare Holdings, Inc. · Jan 2, 2024
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Platform Presentation at the 20th Annual WORLDSymposium™ 2024
Gain Therapeutics, Inc. · Jan 2, 2024
Funded status of largest U.S. corporate pension plans ends 2023 at 100%
Willis Towers Watson Public Limited Company · Jan 2, 2024
Freshpet, Inc. to Participate in the 2024 ICR Conference
Freshpet, Inc. · Jan 2, 2024
Franklin Electric Acquires U.S. Groundwater Distribution Company
Franklin Electric Co., Inc. · Jan 2, 2024
FOX News Channel to Host Primetime Town Hall With Former President Donald Trump on January 10
Fox Corporation · Jan 2, 2024
Fortrea to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Fortrea Holdings Inc. · Jan 2, 2024
Fortinet to Announce Fourth Quarter and Full Year 2023 Financial Results
Fortinet, Inc. · Jan 2, 2024
Flex announces completion of the spin-off of its remaining interest in nextracker
Nextpower Inc. · Jan 2, 2024
FLEX announces completion of the spin-off of its remaining interest in nextracker
Flex Ltd. · Jan 2, 2024
Faraday Future Delivers an FF 91 2.0 to its Newest User, Jim Gao, Vice President of FF’s Intelligent Internet Application Service Platfor...
Faraday Future Intelligent Electric Inc. · Jan 2, 2024
Exelixis to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8, 2024
Exelixis, Inc. · Jan 2, 2024
Evolv Technology to Release Fourth Quarter Financial Results on February 29, 2024
Evolv Technologies Holdings, Inc. · Jan 2, 2024
EverQuote to Participate at the 26th Annual Needham Growth Conference
EverQuote, Inc. · Jan 2, 2024
Euro Manganese Announces Resignation of Board Member
Euro Manganese, Inc. · Jan 2, 2024
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
Establishment Labs Holdings Inc. · Jan 2, 2024
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
PMGC Holdings Inc. · Jan 2, 2024
Element79 Gold Announces Management Cease Trade Order
Element79 Gold Corp. · Jan 2, 2024
Eldorado Gold Announces Appointment of Paul Ferneyhough as Executive Vice President and Chief Financial Officer
Eldorado Gold Corporation · Jan 2, 2024
EchoStar Corporation Completes Merger with DISH Network Corporation
EchoStar Corporation · Jan 2, 2024
Dyne Therapeutics to Host Virtual Event Tomorrow, January 3 at 8: 00 AM ET, to Present Initial Clinical Data from ACHIEVE and DELIVER Trials
Dyne Therapeutics, Inc. · Jan 2, 2024
Donegal Insurance Group Names Two to Posts of Chief Operating Officer, SVP of Field Operations & National Accounts
Donegal Group, Inc. · Jan 2, 2024
DISH Network Convertible Notes Become Convertible Into Shares of EchoStar Corporation
EchoStar Corporation · Jan 2, 2024
Dave George and Jon Sagal Appointed to Bloomin’ Brands Board of Directors
Bloomin' Brands, Inc. · Jan 2, 2024
Dane Leone Joins Xencor as Senior Vice President, Corporate Strategy
Xencor, Inc. · Jan 2, 2024
Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cytokinetics, Incorporated · Jan 2, 2024
Community Trust Bancorp Announces Nicholas Antimisiaris Promoted to Vice President, Corporate Information Security, Resilience and Data O...
Community Trust Bancorp, Inc. · Jan 2, 2024
Columbus McKinnon Announces Kristine Moser as Vice President, Investor Relations and Treasurer
Columbus McKinnon Corporation · Jan 2, 2024
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
CollPlant Biotechnologies Ltd. · Jan 2, 2024
Coherus Announces U.S. Launch of LOQTORZI™
Coherus Oncology, Inc. · Jan 2, 2024
Cogent Biosciences Announces Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Cogent Biosciences, Inc. · Jan 2, 2024
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. · Jan 2, 2024
Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters
Citius Pharmaceuticals, Inc. · Jan 2, 2024
Cipher Mining Announces December 2023 Operational Update
Cipher Digital Inc. · Jan 2, 2024
Check Point Software to Announce Fourth Quarter and Full Year 2023 Financial Results on February 6, 2024
Check Point Software Technologies Ltd. · Jan 2, 2024
Cardlytics Appoints Two New Members to its Board of Directors
Cardlytics, Inc. Common Stock · Jan 2, 2024
Canadian North Resources Reports Results of Borehole Geophysical Surveys Indicating Extensions of Deep Nickel-Copper-PGM Sulfide Zones at...
Canadian North Resources, Inc. · Jan 2, 2024
Caesars Entertainment, Inc. to Report 2023 Fourth Quarter and Full Year Results on February 20, 2024
Caesars Entertainment, Inc. · Jan 2, 2024
Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Cabaletta Bio, Inc. · Jan 2, 2024
BTC Digital Ltd. Announces Purchase of 2,000 Units of T21 Miners
BTC Digital Ltd. · Jan 2, 2024
Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering
Bluejay Diagnostics, Inc. · Jan 2, 2024
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Beam Therapeutics Inc. · Jan 2, 2024
BayFirst Financial Corp. Appoints Thomas G. Zernick as CEO and Names Robin Oliver as President, Effective January 1, 2024
BayFirst Financial Corp. · Jan 2, 2024
Athena Gold Welcomes Eric Sprott as Shareholder and Closes Acquisition of 10 Million Shares in Nubian Resources
Athena Gold Corporation · Jan 2, 2024
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with EMP-01 (R-MDMA)
AtaiBeckley Inc. · Jan 2, 2024
AST SpaceMobile Provides Interim Update on Fundraising
AST SpaceMobile, Inc. · Jan 2, 2024
Asia Pacific Wire & Cable Corporation Limited Reports Third Quarter 2023 Financial Results
Asia Pacific Wire & Cable Corporation Limited · Jan 2, 2024
Ashley Gold Closes Burnhut Property Acquisition and Closes Second Tranche of Financing
Ashley Gold Corp. · Jan 2, 2024
Apogee Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Apogee Therapeutics, Inc. · Jan 2, 2024
Apellis Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Apellis Pharmaceuticals, Inc. · Jan 2, 2024
Anavex Life Sciences Provides an Update on Rett Syndrome Program
Anavex Life Sciences Corp. · Jan 2, 2024
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Amphastar Pharmaceuticals, Inc. · Jan 2, 2024
American Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, Precision...
Cardio Diagnostics Holdings Inc. · Jan 2, 2024
Altimmune Announces Presentation of Pemvidutide Clinical Data at Upcoming NASH-TAG Conference on January 6, 2024
Altimmune, Inc. · Jan 2, 2024
Alnylam to Webcast Presentation at 42nd Annual J.P. Morgan Healthcare Conference
Alnylam Pharmaceuticals, Inc. · Jan 2, 2024
Align Technology to Announce Fourth Quarter and 2023 Results on January 31, 2024
Align Technology, Inc. · Jan 2, 2024
Ainos Regains Compliance with Nasdaq Minimum Bid Price Requirement
Ainos, Inc. · Jan 2, 2024
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
Agios Pharmaceuticals, Inc. · Jan 2, 2024
Aehr Test Systems to Announce Second Quarter Fiscal 2024 Financial Results on January 9, 2024
Aehr Test Systems · Jan 2, 2024
Aditxt, Inc. Regains Compliance with Nasdaq Stockholders’ Equity Requirement
Aditxt, Inc. · Jan 2, 2024